These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20171840)

  • 1. It is "the noise of practice".
    Windeler J
    J Clin Epidemiol; 2010 Jun; 63(6):694; author reply 694-5. PubMed ID: 20171840
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines and consensus statements regarding the conduction and reporting of clinical research studies.
    Falagas ME; Pitsouni EI
    Arch Intern Med; 2007 May; 167(9):877-8. PubMed ID: 17502527
    [No Abstract]   [Full Text] [Related]  

  • 3. European consensus statement on the terminology used in the management of lupus glomerulonephritis.
    Gordon C; Jayne D; Pusey C; Adu D; Amoura Z; Aringer M; Ballerin J; Cervera R; Calvo-Alén J; Chizzolini C; Dayer J; Doria A; Ferrario F; Floege J; Guillevin L; Haubitz M; Hiepe F; Houssiau F; Lesavre P; Lightstone L; Meroni P; Meyer O; Moulin B; O'Reilly K; Praga M; Schulze-Koops H; Sinico R; Smith K; Tincani A; Vasconcelos C; Hughes G
    Lupus; 2009 Mar; 18(3):257-63. PubMed ID: 19213865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quantifiability of medical futility.
    Vinicky JK; Orlowski JP
    J Clin Ethics; 1994; 5(2):147-9. PubMed ID: 7919486
    [No Abstract]   [Full Text] [Related]  

  • 5. Imipramine equivalents.
    Kantor SJ
    J Clin Psychiatry; 1990 Jun; 51(6):257. PubMed ID: 2189871
    [No Abstract]   [Full Text] [Related]  

  • 6. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice.
    J Postgrad Med; 2001; 47(3):199-203. PubMed ID: 11832625
    [No Abstract]   [Full Text] [Related]  

  • 7. The application of good clinical practice to challenge tests.
    Bailey JE
    J Psychopharmacol; 2004 Mar; 18(1):16; author reply 18-9. PubMed ID: 15107178
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 9. Eroding precision in scientific communications: contagion from "the real world".
    Lyles A
    Clin Ther; 2007 Jan; 29(1):182. PubMed ID: 17379059
    [No Abstract]   [Full Text] [Related]  

  • 10. Masking or blinding? An unscientific survey of mostly medical journal editors on the great debate.
    Lang T
    MedGenMed; 2000 Mar; 2(1):E25. PubMed ID: 11104471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorder.
    Montgomery SA; Lecrubier Y; Baldwin DS; Kasper S; Lader M; Nil R; Stein D; Van Ree JM;
    Eur Neuropsychopharmacol; 2004 Oct; 14(5):425-33. PubMed ID: 15336305
    [No Abstract]   [Full Text] [Related]  

  • 12. [Expectations of the bearer of the cost of clinical studies and transformation to care by physicians under contract].
    Perleth M
    Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S72-6. PubMed ID: 15988672
    [No Abstract]   [Full Text] [Related]  

  • 13. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulins in inflammation. Consensus-assisted protocol development and discussion forum of a study protocol on adjuvant treatment of mediastinitis with immunoglobulins (pentaglobulin) after cardiac surgery (ATMI).
    Eur J Surg Suppl; 1999; (584):1-100. PubMed ID: 10917696
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploring the use of the sham design for interventional trials: implications for endoscopic research.
    Wilcox CM
    Gastrointest Endosc; 2008 Jan; 67(1):123-7. PubMed ID: 18155434
    [No Abstract]   [Full Text] [Related]  

  • 17. [Good clinical practice. Reorientation in clinical research. European Society for Good Clincial Practice].
    Spitzer S; Kiesewetter H; Bach R; Gutensohn J; Jung F; Schieffer H; Kleinsorge H
    Dtsch Med Wochenschr; 1993 Jun; 118(22):838-43. PubMed ID: 8504726
    [No Abstract]   [Full Text] [Related]  

  • 18. TERMTrial--terminology-based documentation systems for cooperative clinical trials.
    Merzweiler A; Weber R; Garde S; Haux R; Knaup-Gregori P
    Comput Methods Programs Biomed; 2005 Apr; 78(1):11-24. PubMed ID: 15780886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reading between the lines of clinical trials--I: Design.
    Drug Ther Bull; 1985 Jan; 23(1):1-3. PubMed ID: 3967580
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy.
    Mullen KD
    Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():11-6. PubMed ID: 17295847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.